FDA approves Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 -11

Silver Spring, MD – Today, Friday, October 29th, 2021,  the U.S. Food and Drug Administration (FDA) authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 Coronavirus to include children 5 through 11 years of age.

The authorization was based on the FDA’s thorough and transparent evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favor of making the vaccine available to children in this age group.

[Read more]

Tennessee Department of Health Offering Booster Dose of Pfizer COVID-19 Vaccine

Nashville, TN – The Tennessee Department of Health has begun offering booster doses of COVID-19 Coronavirus vaccine to certain populations.

A single dose booster of the Pfizer-BioNTech COVID-19 Coronavirus vaccine can be administered for individuals who met these criteria:

[Read more]

Tennessee Department of Health offers Third Dose of mRNA Vaccine

Nashville, TN – The Tennessee Department of Health (TDH) is acting upon recent guidance from the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) regarding an additional dose of the COVID-19 mRNA vaccine for moderately and severely immunocompromised individuals.

[Read more]

Tennessee Department of Health announces Moderna COVID-19 Vaccine to arrive next Week

Nashville, TN – The Tennessee Department of Health today announced the state expects to receive its first shipment of the Moderna COVID-19 vaccine on or around December 21st, 2020.

Tennessee expects to receive an initial allocation of a total of 115,000 doses of the Moderna COVID-19 vaccine over the next two weeks, following Emergency Use Authorization issued by the U.S. Food and Drug Administration (FDA) and recommendations released by the Advisory Committee on Immunization Practices.

[Read more]

Tennessee receives first shipment of Pfizer COVID-19 Vaccination

Nashville, TN – The Tennessee Department of Health today, Monday, December 14th, 2020 announced the state has received its first shipment of the Pfizer-BioNTech COVID-19 vaccine ahead of statewide shipment on Thursday.

The state obtained an early shipment of 975 doses to hold as an emergency backup supply should any receiving hospital’s supply be damaged.

[Read more]

FDA Issues Emergency Use Authorization for First COVID-19 Vaccine

Silver Spring, MD – The U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.

The emergency use authorization allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the United States.

[Read more]

FDA Statement on Vaccines, Related Biological Products Advisory Committee Meeting

The following is attributed to FDA Commissioner Stephen M. Hahn, M.D., and Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research.

Silver Spring, MD – Following yesterday’s positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 Coronavirus vaccine, the U.S. Food and Drug Administration (FDA) has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization.

[Read more]

FDA Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Pfizer COVID-19 Vaccine Candidate

Silver Spring, MD – The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on December 10th, 2020 to discuss the request for emergency use authorization (EUA) of a COVID-19 Coronavirus vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.

[Read more]